Curzion Pharmaceuticals

Promedior

This biotechnology company develops drug therapies to treat rare fibrotic diseases for patients with conditions such as idiopathic pulmonary fibrosis and myelofibrosis.

Contineum Therapeutics

This company develops oral small-molecule therapies for patients with inflammatory, fibrotic and neurological diseases, including idiopathic pulmonary fibrosis and progressive multiple sclerosis.

AgomAb Therapeutics

This biopharmaceutical company develops therapies to treat fibrotic and inflammatory diseases for patients with conditions such as Crohn's disease and pulmonary fibrosis.

Curileum

The company develops novel therapies and small molecule drugs to restore gastrointestinal tissue health for patients with bowel cancer and inflammatory bowel disease.

SFA Theraputics

This biopharmaceutical company develops oral small-molecule drugs for patients suffering from autoimmune diseases, chronic inflammatory conditions, and various types of liver cancer.

Curegenix

This company develops small-molecule chemical drugs for the treatment of tumours and organ fibrosis for patients with stem cell related diseases.

Celea Therapeutics

The company develops deupirfenidone, an antifibrotic medicine for patients with idiopathic pulmonary fibrosis and other serious respiratory diseases.

Avalyn Pharma

The company develops inhaled medicines to treat patients with rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases.